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OBJECTIVE — To compare mortality rates for individuals with diabetes with and without a
history of foot ulcer (HFU) and with that for the nondiabetic population.
RESEARCH DESIGN AND METHODS — This population-based study included 155
diabetic individuals with an HFU, 1,339 diabetic individuals without an HFU, and 63,632
nondiabetic individuals who were all followed for 10 years with mortality as the end point.
RESULTS — During the follow-up period, a total of 49.0% of diabetic individuals with an
HFU died, compared with 35.2% of diabetic individuals without an HFU and 10.5% of those
without diabetes. In Cox regression analyses adjusted for age, sex, education, current smoking,
andwaistcircumference,havinganHFUwasassociatedwithmorethanatwofold(2.29[95%CI
1.82–2.88]) hazard risk for mortality compared with that of the nondiabetic group. In corre-
sponding analyses comparing diabetic individuals with and without an HFU, an HFU was
associated with 47% increased mortality (1.47 [1.14–1.89]). Signiﬁcant covariates were older
age, male sex, and current smoking. After inclusion of A1C, insulin use, microalbuminuria,
cardiovascular disease, and depression scores in the model, each was signiﬁcantly related to life
expectancy.
CONCLUSIONS — AN HFU increased mortality risk among community-dwelling adults
and elderly individuals with diabetes. The excess risk persisted after adjustment for comorbidity
and depression scores, indicating that close clinical monitoring might be warranted among
individuals with an HFU, who may be particularly vulnerable to adverse outcomes.
Diabetes Care 32:2193–2199, 2009
H
ospital-based studies have shown
that mortality rates in individuals
with diabetic foot ulcers are about
twice those observed in individuals with
diabetes without foot ulcers (1,2). A dia-
betic foot ulcer reﬂects the presence of
underlying pathological conditions, and
theriskofrecurrentulcersishigh(3,4).It
has been suggested that the elevated mor-
tality rate among individuals with dia-
betic foot ulcers is related to comorbid
diseasesuchascardiovasculardiseaseand
nephropathy (5) or to psychological fac-
tors including depression (6). Although
the mortality rate in individuals with dia-
betes is high, no large population-based
studies have examined the impact on
mortality of a history of foot ulcers (HFU)
among individuals with diabetes.
Thepurposeofthisstudywastocom-
pare mortality rates for individuals with
diabetes reporting an HFU with those for
individuals without an HFU and the non-
diabeticpopulation.Theseissueswerein-
vestigated in the Nord-Trøndelag Health
Study (HUNT 2), which includes a very
large population-based sample of men
and women from a well-deﬁned geo-
graphic area. Participants with self-
reported diabetes were well characterized
with regard to their diabetes, and infor-
mation on demographics, lifestyle, and
prevalent disease including depression
was available.
RESEARCH DESIGN AND
METHODS— TheHUNT2studywas
conducted during 1995–1997 and was
approved by the Norwegian Data Inspec-
torate and the Regional Committee for
Medical Research Ethics. Participation
was voluntary, and each participant
signed a consent form.
The HUNT 2 study was described
previously (7,8). In brief, all inhabitants
of Nord-Trøndelag County aged 20
years were invited to participate (n 
92,434). A questionnaire was mailed to
each person along with an invitation to
attendaclinicalexamination.Ofthosein-
vited, 65,604 individuals (71%) at-
tended. Participants who responded
positively to the question, “Do you have
or have you had diabetes?” were classiﬁed
as having diabetes (n  1,972) and were
invited to take part in the diabetes sub-
study. Those who in an additional ques-
tionnaire answered positively to the
question, “Have you had a foot ulcer that
required more than three weeks to heal?”
were classiﬁed as having an HFU (n 
155), and those who responded nega-
tively were classiﬁed as having diabetes
without an HFU (n  1,339). Those clas-
siﬁed as having diabetes but who did not
take part in the diabetes substudy or did
not answer the foot ulcer question were
excludedfromtheanalyses(n478)(7).
Some 63,632 participants reported not
having diabetes. Thus, the current study
includes a total of 65,126 participants.
In HUNT 2, a nonfasting venous se-
rum sample was analyzed for glucose; for
those who reported diabetes, an EDTA
whole-bloodsamplewasalsoanalyzedfor
A1C. Those who reported diabetes were
given a follow-up appointment (74.8%
participated) at which a fasting blood
sample was drawn and analyzed for glu-
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Participants who reported diabetes re-
ceived tubes for collecting three consecu-
tive ﬁrst morning urine samples. Among
the 1,494 participants with or without an
HFU,94.1%returnedthesamples,which
were analyzed for albumin and creatinine
(8). An albumin-to-creatinine ratio 2.5
mg/mmol in at least two of the three
urine samples was used to deﬁne mi-
croalbuminuria, as recommended by
Hallan et al. (9).
Other variables included age, sex,
BMI (weight in kilograms divided by the
square of height in meters), and waist cir-
cumference. Education was categorized
as 10 years or 10 years. Smoking was
classiﬁed as current smoking or not. The
baseline questionnaire included informa-
tion about angina pectoris, myocardial
infarction, and stroke; those who re-
sponded positively to one or more of
theseitemsweredeﬁnedashavingcardio-
vascular disease. Hypertension was de-
ﬁned as blood pressure of 140/90
mmHg or as current use of antihyperten-
sive drugs. Exercise was dichotomized as
1 h of physical activity per week or 1
h. Other diabetes-related questions from
the diabetes substudy included treat-
ment, diabetes duration, eye problems
due to diabetes, and amputation. Those
reporting amputation of a toe, calf/knee,
or femur were categorized as having any
lower-limb amputation.
Depression was assessed by the Hos-
pital Anxiety and Depression Scale
(HADS) (10,11). This instrument in-
cludes seven items measuring depression
(HADS-D subscale). Each item is scored
from 0 to 3; thus, the maximum score is
21oneachofthesubscales.Higherscores
indicate higher levels of symptom load.
Missing substitution was performed for
individuals who responded to ﬁve or six
of the seven HADS-D questions. This was
done by multiplying the score obtained
by 7/5 if ﬁve of the seven questions were
answered and by 7/6 if six questions were
answered. Such missing substitution was
needed for 5.8% of the HADS-D scale;
4.6% of the respondents answered fewer
than ﬁve questions on the HADS-D and
wereexcluded.Casenesswasdeﬁnedbya
score of 8 on the HADS-D. This cutoff
levelhasbeenshowntooptimallybalance
sensitivity and speciﬁcity on receiver-
operating characteristic curves (11) and
wasalsoappliedinourstudy.Factoranal-
ysis of HADS in HUNT was reported to
result in a two-factor solution consistent
with the two subscales, anxiety and de-
pression.Cronbach’svaluesforinternal
consistency for the anxiety and depres-
sion subscales in HUNT were reported as
0.80 and 0.76, respectively (12).
Follow-up
Participants were followed for up to 10
years with mortality as the end point. In-
formationonmortalitywasobtainedfrom
the Norwegian Causes of Death Registry
using the Norwegian 11-digit personal
identitynumberuniqueforeachresident.
Information on individuals who emi-
gratedfromNord-TrøndelagCountydur-
ing the follow-up period was estimated to
be negligible (0.5%, http://www.ssb.
no/english/subjects/02/02/20/innvutv_
en/tab-2009–05-07–02-en.html).
Mortality diagnoses were coded ac-
cording to the ICD-10. The main mor-
tality diagnoses were categorized into
diseases as follows: diabetes (E10–14),
ischemic heart disease (I20–25), cere-
brovasculardisease(I60–69),othercir-
culatory diseases (I00–15, I26–28,
I30–52,I70–79,I80–99),renaldisease
(N00–39), cancer (C), and other dis-
eases (A, B, D, E00–07, E15–90, F–H,
J–M, N40–99, O–Y).
Statistical analyses
Power calculations were performed be-
fore the study and showed a statistical
power of 78% to detect an increased risk
of 33% among the foot ulcer group com-
pared with the population with diabetes
without an HFU, assuming a mortality of
30% during the follow-up in the latter
group. We used t tests and 
2 tests to
compare characteristics of the three sub-
groups at baseline.
Cox proportional hazards regression
analyses were used to estimate mortality
rate ratios (hazard ratios [HRs]) and 95%
CI from the date of inclusion in the study
(1995–1997) to 31 December 2005. We
created dummy variables for the diabetic
patients without an HFU and the diabetic
patientswithanHFUsuchthattheHRfor
each category represents the comparison
of that category with the HR for the non-
diabetic population. Preliminary, simple
Cox regression analyses were performed
for all baseline covariates and all-cause
mortality. For covariates with 2% miss-
ing data in the foot ulcer group, separate
“unknown”categorieswereused.Thisin-
volved education (n  16), waist circum-
ference (n  5), microalbuminuria (n 
10), and depression (n  11).
Multiple Cox proportional hazards
regression analyses were then performed
with adjustment for other known risk
factors for mortality. Covariates were
organized thematically in blocks, and
increasingly complex models were devel-
oped by adding one set of variables at a
time using forced entry. We chose this
model because diabetes increases the
riskofcardiovasculardiseaseandthere-
fore the development of cardiovascular
disease is in the causal pathway, leading
from diabetes to a higher risk of death
(13).
Variable selection in multivariable
modelingwasmadeaprioribasedonpre-
vious knowledge, and assessment of the
variable in relation to time, cause, and ef-
fect.Forexample,ahistoryofamputation
was not taken into the model because this
most probably occurred after a diabetic
foot ulcer. Severity of illness (judged by
insulin use and A1C), microalbuminuria,
a history of cardiovascular disease, and
depression (HADS-D score 8) were en-
tered into the model.
The two diabetic groups were ﬁrst
compared with the nondiabetic popula-
tion after adjustment for demographic
factors, lifestyle variables, cardiovascular
disease, and depression. Covariates in
model 1 included age (continuous), male
sex (no or yes), level of education (high,
low, or unknown), current smoking (no
or yes), and high waist circumference of
102 cm in men or 88 cm in women
(no, yes, or unknown). Covariates in
model 2 included cardiovascular disease
status (no or yes) and depression
(HADS-D score 8) (no, yes, or
unknown).
Analyses involving only the diabetic
groupswereadjustedsimilarlyforage,male
sex, level of education, current smoking,
andwaistcircumference(model3).Thefol-
lowing additional factors were also in-
cluded: cardiovascular status (no or yes)
and depression (HADS-D score 8) (no,
yes, or unknown) (model 4), mi-
croalbuminuria (no, yes, or unknown),
A1C (continuous), and insulin use (no
or yes) (model 5).
Cox regression analyses were also
performedtotestforpossibleinteractions
between the main exposure (nondiabetic
subjects and diabetic subjects with and
without an HFU) and the other covariates
in the model among individuals with di-
abetes. Kaplan-Meier survival curves
were estimated to describe all-cause mor-
tality in the subgroups. Statistical signiﬁ-
cancewasassignedasP0.05.Statistical
analyseswereconductedusingSPSS(ver-
sion 16.0).
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Baseline characteristics
Compared with the nondiabetic sample,
those with an HFU were older and had
higher BMI, waist circumference, and de-
pression scores; a higher proportion were
male and physically inactive with low ed-
ucation, angina pectoris, myocardial in-
farction, stroke, and hypertension; and a
lower proportion were smokers. In a
comparison of the two diabetic groups,
thosewithanHFUhadhighermeanwaist
circumference and A1C, and a larger pro-
portion were physically inactive, used in-
sulin, had a long diabetes duration, had
microalbuminuria, and had a history of
stroke, peripheral vascular surgery, eye
problemsduetodiabetes,andlower-limb
amputations (Table 1).
Mortality
During the follow-up period, 49% of the
155 diabetic individuals with an HFU
died compared with 35.2% of the 1,339
diabetic individuals without an HFU and
10.5%ofthe63,632nondiabeticindivid-
uals.AmongindividualswithanHFU,the
main causes of death were cardiovascular
events (48.7%), diabetes (23.7%), and
cancer (14.5%). Corresponding ﬁgures
among those with diabetes without an
HFU were 50.1, 11.7, and 18.6% and
among the nondiabetic group were 44.9,
0.5, and 27.5%, respectively. The mortal-
ity rates from cardiovascular causes were
not statistically different between the dia-
betic groups, although patients with an
HFU had more prevalent cardiovascular
disease and more cardiovascular disease
risk factors at baseline than those without
an HFU. After adjustment for age, sex,
education,smoking,andwaistcircumfer-
ence diabetic individuals with and with-
out an HFU had a signiﬁcantly higher
mortality rate than that for the nondia-
beticgroup(HR2.29[95%CI1.82–2.88]
and 1.70 [1.54–1.86], respectively) (Ta-
ble 2, model 1). Covariates signiﬁcantly
associated with increased mortality risk
were older age, male sex, low education,
smoking, and larger waist circumference.
The risk of mortality associated with hav-
ing an HFU did not change markedly
when cardiovascular disease and depres-
sion (HADS-D score 8) also were in-
cluded in the model (Table 2, model 2).
Among individuals with diabetes, af-
ter adjustment for age, sex, education,
smoking, and waist circumference, an
HFUwasassociatedwitha47%increased
Table 1—Description of the study population; the HUNT 2 study
Nondiabetic
subjects*
Diabetic subjects
without an HFU*
Diabetic subjects
with an HFU* P† P‡
n 63,632 1,339 155
Demographic characteristics
Age (years) 49.7  17.3 65.6  13.6 67.2  14.0 0.001 0.157
Male sex (%) 46.7 49.7 56.8 0.012 0.097
Single (%) 40.1 38.1 45.8 0.150 0.064
Education (10 years) (%) 64.0 37.7 33.8 0.001 0.367
Lifestyle characteristics
BMI (kg/m
2) 26.3  4.1 28.9  4.8 29.3  5.3 0.001 0.396
Waist circumference (cm) 86.2  11.6 95.0  12.0 98.2  12.3 0.001 0.002
Physical activity 1 h/week (%) 19.8 27.5 37.2 0.001 0.026
Current smokers (%) 29.0 16.8 11.1 0.001 0.070
Cardiovascular disease status
Self-reported stroke (%) 1.8 5.0 12.2 0.001 0.001
Self-reported myocardial infarction (%) 3.0 12.6 15.3 0.001 0.345
Self-reported angina pectoris (%) 4.6 18.5 22.0 0.001 0.307
Hypertension 23.9 56.4 57.4 0.001 0.81
Subgroups of diabetes
Type 1 (%) — 16.9 26.0
Type 2 (%) — 83.1 74.0
Diabetes-speciﬁc variables
A1C (% units) — 8.1  1.7 8.4  2.0 — 0.015
Insulin use (%) — 31.8 43.5 — 0.004
Microalbuminuria§ — 27.3 40.0 — 0.001
Duration of diabetes (years) (median) — 6.0 10.0 — 0.001
Peripheral vascular surgery (%) — 2.7 10.7 — 0.001
Eye problems due to diabetes (%) — 11.9 24.8 — 0.001
Any lower limb amputations (%) — 0.7 5.2 — 0.001
Psychological assessment
HADS-D score (0–21) 3.5  3.1 4.3 (SD 3.4) 4.7 (SD 3.6) 0.001 0.180
HADS-D (score 8) (%) 10.8 17.1 18.8 0.002 0.614
HADS-D (score 11) (%) 3.2 6.0 7.6 0.002 0.439
Data are means  SD or %. *Sample sizes vary somewhat depending on the actual completion of the different tests and questionnaires. †Signiﬁcance of the t test or

2testfordifferencebetweenparticipantswithahistoryofdiabeticfootulcersandthosewithoutdiabetes.‡Signiﬁcanceofthettestor
2testfordifferencebetween
participants with and without a history of diabetic foot ulcer. §Microalbuminuria was deﬁned as albumin-to-creatinine ratio 2.5 mg/mmol in at least two of three
urine samples.
Iversen and Associates
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associated with mortality were older age,
male sex, and smoking (Table 2, model
3). The association between an HFU and
mortality did not change markedly when
cardiovascular disease and depression
(HADS-D score 8) were included in the
model. When A1C, insulin use, and mi-
croalbuminuria entered the model, the
HR for an HFU was slightly reduced to
1.41[95%CI1.09–1.82](Table2,model
5). Signiﬁcant predictors for reduced life
expectancy in the ﬁnal model were older
age, male sex, smoking, the presence of
cardiovascular disease and depression
(HADS-D score 8), microalbuminuria,
A1C, and insulin use. To study the effect
of A1C among diabetic individuals with
an HFU only, we repeated the analyses
restricted to this subgroup and found an
effect of A1C that was slightly stronger
than that among all individuals with dia-
betes, although not signiﬁcant (HR 1.11
[0.97–1.28]).
We included those with missing in-
formation for education, waist circumfer-
ence, microalbuminuria, and depression
as separate subgroups in the Cox regres-
sion analyses. In general, the categories
for missing values tended to have higher
HR estimates (not shown in the table),
although these were not signiﬁcant,
which probably reﬂects the small num-
bers. We also performed additional anal-
yses that excluded individuals with
diabetes who reported a history of ampu-
tation, but this did not alter the results
markedly. Diabetes classiﬁcation and di-
abetes duration were also included in the
Cox regression analyses. The estimated
effects of an HFU changed only margin-
ally, and these covariates were not signif-
icantly associated to mortality.
A total of 478 individuals with diabe-
tes did not participate in the substudy on
diabetes or did not answer the question
onfootulcers.Toassessthevalidityofthe
ﬁndings among those with diabetes, we
compared those who completed the foot
ulcer question with those who did not,
with regard to demographics, prevalent
disease, and health behaviors and found
that those who did not complete this
question had more advanced disease.
To illustrate the excess mortality at-
tributabletodiabeteswithandwithoutan
HFU, Kaplan-Meier curves were drawn
for data stratiﬁed into age-groups 65–74
and 75 years. As seen in Fig. 1, partici-
pants with diabetes and an HFU consis-
tently had the highest mortality rates.
Tests for interactions revealed inter-
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thattheeffectofagewaslessimportantfor
those with an HFU (P  0.040).
CONCLUSIONS — In this 10-year
follow-upstudy,anHFUwasassociated
with more than a twofold elevated risk
of mortality compared with the nondi-
abetic group and an 40% higher mor-
tality compared with participants with
diabetes but without an HFU. Com-
pared with diabetes without an HFU,
the excess risk was explained only
partly by older age, male sex, higher
A1C, current smoking, insulin use, mi-
croalbuminuria, cardiovascular disease,
and depression.
This large community-based study
showed that foot ulceration increases
mortality risk among individuals with di-
abetes. As far as we are aware, this is the
ﬁrst such study to identify a higher mor-
talityrateinindividualswithdiabetesand
an HFU among community-dwelling
adults and elderly individuals. Previous
studies have to our knowledge included
samples from hospitals, foot clinics, or
outpatient settings (2,14,15). A substan-
tialproportionofpatientswithfootulcers
are treated in primary care settings, and
withtheincreasingprevalenceofdiabetes
worldwide (16), the number of patients
with diabetes and an HFU will increase
over the next decade. Most of these pa-
tients are expected to have limited or in-
frequent access to multidisciplinary
treatment teams (17). The present study
underlines the importance of organizing
future health care services with follow-up
Figure. 1—Kaplan-Meier survival curves (all-cause mortality) comparing nondiabetes, diabetes, and diabetes with an HFU subgroups by sex and
age. Dotted line, nondiabetes; thin line, diabetes without an HFU; thick line, diabetes with an HFU. A: Estimates for men aged 65–74 years. B:
Estimates for men aged 75 years. C: Estimates for women aged 65–74 years. D: Estimates for women aged 75 years.
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itoring of individuals with an HFU in pri-
mary care.
In a 5-year observational study in
Sweden, patients with diabetic foot ulcers
attending a foot clinic had a twofold in-
crease in mortality rates compared with
nondiabetic individuals, after adjustment
for age and sex (1). We found a similar
increased risk after adjustment for addi-
tional potential confounders and after a
longerfollow-upperiod.Inastudyofam-
bulatory male patients with diabetes (2),
the relative risk of death during 4 years of
follow-up was 2.39 in those who devel-
oped a new foot ulcer compared with
those who did not. The excess mortality
rate was substantially higher than that in
our study. This difference might reﬂect
the more advanced illness in hospital-
based patients; however, the study by
Boyko et al. (2) was conducted between
1990 and 1994, and diabetes treatment
has improved in recent years (18). Al-
though the survival rate among individu-
als with an HFU might have improved in
recent years, our data indicate continued
excessmortalityforthosewithanHFU.In
addition, those with an HFU had a larger
extent of severe diabetes complications
compared with those with diabetes with-
out an HFU. Further, among those with
an HFU, a higher proportion of deaths
was caused by diabetes and its complica-
tions, whereas the effect of age was less
important among those with an HFU.
To our knowledge, our results relat-
ing poor glycemic control to higher mor-
tality in individuals with diabetes and an
HFU are novel and in contrast to the re-
sults presented by Winkley et al. (4), who
reported that better glycemic control was
signiﬁcantly associated with higher mor-
tality in individuals with a diabetic foot
ulcer after 18 months of follow-up. Our
ﬁndings underline the importance of
early identiﬁcation of foot ulcers and in-
tensiﬁed treatment at an early stage.
Depression has previously been asso-
ciatedwithincreasedmortalityinindivid-
ualswithdiabetes(19,20).Ismailetal.(6)
found that one-third of individuals with
their ﬁrst foot ulcer suffered from depres-
sion and that this condition was associ-
ated with increased mortality. Results
from the present study support an in-
creased risk of mortality among those de-
pressed, over and beyond the increased
risk associated with an HFU. Systematic
monitoring and treatment of depression
amongthosewithanHFUshouldbecon-
sidered (4).
Previous longitudinal studies of indi-
viduals with diabetes and an HFU have
includedmainlyhospitalorfootclinicpa-
tients (1,2,14). The present long-term
study of 60,000 men and women in-
cluding 1,494 individuals with validated
diabetes (21) support these previous
ﬁndings.
As with all large-scale epidemiologic
studies, ours also has inherent shortcom-
ings. During the 10-year follow-up pe-
riod, new cases of diabetes probably
developed, but the only information we
have among nondiabetic subjects is that
0.5%ofdeathswerediabetes-related.The
inclusion of an unknown number of sub-
jects with diabetes in the nondiabetic
group at baseline may inﬂuence the ﬁnd-
ings. Among those without known diabe-
tes, a total of 62,757 delivered a
nonfastingbloodglucose(venousserum).
The 217 individuals with a nonfasting
glucose 11 mmol/l were contacted and
advised to contact their general practitio-
ner. In the analysis of the present study
these 0.003% (217 of 62,757) were not
deﬁned as having diabetes owing to un-
certainty. Because this is a very low num-
ber, it is unlikely that any of the risk
estimates have been inﬂuenced by these
individuals. It is likely that these proce-
duresunderestimatedthenumberofsub-
jects with diabetes. Further, among
individualswhoreportedanHFUatbase-
line, we have no information about the
development of HFU after baseline. A
closer follow-up of these individuals
would have enabled more detailed analy-
ses to determine the real causes of the in-
creasedmortalityinthisgroup.Wefound
that the diabetic individuals who did not
respond to the questionnaire on foot ul-
cers reported otherwise more advanced
disease (7), corresponding to results from
other studies of nonresponders (22). The
mortality risk associated with an HFU in
the present study might therefore have
been underestimated.
In previous studies the threshold of
microalbuminuria varied from 2.5 to 3.5
mg/mmol for men and women (9). In the
present study we used a cutoff of 2.5 mg/
mmol for both sexes. Thus, the results of
the present study might overestimate the
proportion of women with microalbu-
minuria. Finally, compared with other
studies(1,23),arelativelylowproportion
of participants reported a history of am-
putation, which may be explained by re-
cruitment procedures that made it difﬁcult
forhouse-boundorinstitutionalizedindi-
viduals to participate. Conversely, these
two studies are from specialized foot care
clinics and probably included individuals
with more advanced disease and com-
plications.
In summary, an HFU in those with di-
abetes among community-dwelling adults
and elderly individuals was signiﬁcantly re-
latedtoincreasedmortality.Thisexcessrisk
persisted after adjustment for relevant co-
variates of comorbidity and depression
scores, thus indicating that close clinical
monitoringiswarrantedamongindividuals
with an HFU, who may be particularly vul-
nerable for adverse outcomes.
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